Applied Therapeutics, Inc. (APLT) Financials
APLT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 151.2 million | 83.9 million |
| 2023-12-31 | 54.8 million | 72.0 million |
| 2023-09-30 | 45.2 million | 56.2 million |
| 2023-06-30 | 43.6 million | 48.0 million |
APLT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -18.9 million | 2.4 million |
| 2023-12-31 | -17.0 million | 1.6 million |
| 2023-09-30 | -14.7 million | 1.8 million |
| 2023-06-30 | -16.5 million | 1.8 million |
APLT Net Income
No data available :(
APLT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 146.5 million | - | 343000 |
| 2023-12-31 | 49.9 million | - | 467000 |
| 2023-09-30 | 37.5 million | - | 535000 |
| 2023-06-30 | 35.6 million | - | 656000 |
APLT Shares Outstanding
APLT Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | - | 190000 | 9.1 million | - |
| 2023-12-31 | - | 15.3 million | 5.0 million | - |
| 2023-09-30 | - | 10.8 million | 4.7 million | - |
| 2023-06-30 | - | 11.9 million | 5.3 million | - |
APLT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 190000 | 119000 |
| 2023-12-31 | -667000 | 347000 |
| 2023-09-30 | - | 118000 |
| 2023-06-30 | - | 115000 |
APLT
Price: $4.19
52 week price:
Earnings Per Share: -1.42 USD
P/E Ratio: -2.42
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 546852
Market Capitalization: 530.2 million